Author:
Lunzer Raimund,Koch Robert
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Proft F, et al. Ther Adv Musculoskelet Dis. 2018;10:129–39.
2. Sturm, et al. Leitlinie M. Crohn, Z Gastro. 2022;60:332–418.
3. Zioga, et al. Med J Rheuma. 2022;33(Suppl 1):126–36.
4. Lauper K, Leeb B, et al. Evaluation of Treatment Discontinuation Due to Adverse Events, and the Effect of Cardiovascular Risk Factors or Type of JAK-inhibitors: An International Collaboration of Registries of Rheumatoid Arthritis Patients. ACR. 2022;.
5. Vavricka SR, et al. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21(8):1982–92.